Adjuvant CDK4 and 6 Inhibition to Prevent Recurrences in High-Risk HR+/HER2- Early Breast Cancer

Описание к видео Adjuvant CDK4 and 6 Inhibition to Prevent Recurrences in High-Risk HR+/HER2- Early Breast Cancer

Chair & Presenter, Erika Hamilton, MD, and Professor Stephen Johnston, MA, PhD, discuss Breast Cancer in this CME/MOC/CC/NCPD/CPE activity titled “How to Harness Adjuvant CDK4 and 6 Inhibition to Prevent Recurrences in High-Risk HR+/HER2- Early Breast Cancer: New Goals and Better Tools to Close the Gaps.” For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/CC/NCPD/CPE information, and to apply for credit, please visit us at PeerView.com/WFC865. CME/MOC/CC/NCPD/CPE credit will be available until April 28, 2023.

Комментарии

Информация по комментариям в разработке

Похожие видео